Symbol="FDMT"
AssetType="Common Stock"
Name="4D Molecular TherapeuticsÂ Inc"
Description="4D Molecular Therapeutics, Inc., a clinical-stage gene therapy company, develops candidate products using its adeno-associated virus vectors. The company is headquartered in Emeryville, California."
CIK="1650648"
Exchange="NASDAQ"
Currency="USD"
Country="USA"
Sector="LIFE SCIENCES"
Industry="BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)"
Address="5858 HORTON STREET #455, EMERYVILLE, CA, US"
FiscalYearEnd="December"
LatestQuarter="2023-06-30"
MarketCapitalization="699067000"
EBITDA="-113816000"
PERatio="None"
PEGRatio="None"
BookValue="7.74"
DividendPerShare="0"
DividendYield="0"
EPS="-3.37"
RevenuePerShareTTM="0.067"
ProfitMargin="0"
OperatingMarginTTM="-51.4"
ReturnOnAssetsTTM="-0.224"
ReturnOnEquityTTM="-0.373"
RevenueTTM="2285000"
GrossProfitTTM="-77124000"
DilutedEPSTTM="-3.37"
QuarterlyEarningsGrowthYOY="0"
QuarterlyRevenueGrowthYOY="0.475"
AnalystTargetPrice="38.63"
TrailingPE="-"
ForwardPE="-"
PriceToSalesRatioTTM="378.9"
PriceToBookRatio="3.014"
EVToRevenue="277.01"
EVToEBITDA="-5.32"
Beta="2.338"
num_52WeekHigh="26.49"
num_52WeekLow="6.58"
num_50DayMovingAverage="18.69"
num_200DayMovingAverage="18.68"
SharesOutstanding="41885400"
DividendDate="None"
ExDividendDate="None"
symbol="FDMT"
open="16.72"
high="16.78"
low="16.37"
price="16.66"
volume="192521.00"
latest_trading_day="2023-08-15"
previous_close="16.74"
change="-0.08"
change_percent="-0.4779%"
aroon_positive_momentum_days="0"
aroon_negative_momentum_days="61"
trend_strength="Absent or Weak Trend"
buying_signal="Weak Sell Signal"
volume_analysis="Target Volume"
value_analysis="Expected Range"
Aroon_change="FALSE"
Aroon_momentum="39"
Volume_recent_avg="505634"
Change_recent_avg="-0.01"
Delta_recent_avg="1.17"
Variance_recent_avg="0.59"
Change_ratio_recent_avg="-0.15"
RSI_change="FALSE"
ADX_change="FALSE"

event="FALSE"
Aroon_signal="negative"
Aroon_change="FALSE"
Aroon_momentum_positive="39"
Aroon_momentum_negative="61"
image_negative_thumbnail_id_1="138"
image_negative_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/05/MI_Finance_Negative_Landscape_0038.jpeg"
image_negative_thumbnail_id_2="503"
image_negative_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0102.jpeg"
image_neutral_thumbnail_id_1="554"
image_neutral_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0045.jpeg"
image_neutral_thumbnail_id_2="552"
image_neutral_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0047.jpeg"
image_positive_thumbnail_id_1="619"
image_positive_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0089.jpeg"
image_positive_thumbnail_id_2="702"
image_positive_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0006.jpeg"
image_professor_thumbnail_id_1="1182"
image_professor_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0016.jpeg"
image_professor_thumbnail_id_2="1172"
image_professor_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0006.jpeg"
